Nautilus Biotechnology announces 2024 annual meeting voting results

Nautilus Biotechnology, Inc.

Elected Melissa Epperly (92.1M for, 674K withheld), Matthew L. Posard (90.6M for, 2.1M withheld), Karen Akinsanya (89.9M for, 2.8M withheld) as Class III directors.
Ratified PricewaterhouseCoopers LLP as independent auditor for FY2024 with 105.1M votes for, 172.9K against, 69.2K abstentions.
Approximately 84% of outstanding shares (105.3M of 125.3M) represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.